DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Müller T.
Pharmacokinetic considerations for the use of levodopa in the treatment of Parkinson disease: Focus on levodopa/carbidopa/entacapone for treatment of levodopa-associated motor complications.
Clin Neuropharmacol 2013;
36: 84-91
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.